Cargando…

Vaccines and SARS-CoV-2 variants: the urgent need for a correlate of protection

Detalles Bibliográficos
Autor principal:	Karim, Salim S Abdool
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Ltd. 2021
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7984864/ https://www.ncbi.nlm.nih.gov/pubmed/33765410 http://dx.doi.org/10.1016/S0140-6736(21)00468-2

Ejemplares similares

New SARS-CoV-2 Variants — Clinical, Public Health, and Vaccine Implications
por: Abdool Karim, Salim S., et al.
Publicado: (2021)

Immediate need for next-generation and mutation-proof vaccine to protect against current emerging Omicron sublineages and future SARS-CoV-2 variants: An urgent call for researchers and vaccine companies – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

Tracking immune correlates of protection for emerging SARS-CoV-2 variants
por: Nilles, Eric J, et al.
Publicado: (2023)

Omicron SARS-CoV-2 variant: a new chapter in the COVID-19 pandemic
por: Karim, Salim S Abdool, et al.
Publicado: (2021)

Besides human booster doses: Could vaccinating highly susceptible animals to SARS-CoV-2 be the needed urgent strategic step?
por: Saied, AbdulRahman A.
Publicado: (2022)

Recombinant SARS-CoV-2 variants XD, XE, and XF: The emergence of recombinant variants requires an urgent call for research – Correspondence
por: Chakraborty, Chiranjib, et al.
Publicado: (2022)

There is an urgent need for safer anti-SARS-CoV-2 vaccines
por: Finsterer, Josef
Publicado: (2022)

More data needed on efficacy and safety of monovalent vaccines against SARS-CoV-2 omicron variants
por: Monach, Paul A, et al.
Publicado: (2023)

SARS-CoV-2 Brazil variants in Latin America: More serious research urgently needed on public health and vaccine protection
por: Chakraborty, Chiranjib, et al.
Publicado: (2021)

Neutralization of the SARS-CoV-2 Mu Variant by Convalescent and Vaccine Serum
por: Uriu, Keiya, et al.
Publicado: (2021)

Viral Dynamics of SARS-CoV-2 Variants in Vaccinated and Unvaccinated Persons
por: Kissler, Stephen M., et al.
Publicado: (2021)

Hybrid SARS-CoV-2 variants
por: Rahimi, Farid, et al.
Publicado: (2022)

SARS-CoV-2 variants and ending the COVID-19 pandemic
por: Fontanet, Arnaud, et al.
Publicado: (2021)

Protection with a Third Dose of mRNA Vaccine against SARS-CoV-2 Variants in Frontline Workers
por: Yoon, Sarang K., et al.
Publicado: (2022)

Protection against the Omicron Variant from Previous SARS-CoV-2 Infection
por: Altarawneh, Heba N., et al.
Publicado: (2022)

Neutralising antibody titres as predictors of protection against SARS-CoV-2 variants
por: Pallett, Scott J C, et al.
Publicado: (2022)

Vaccine booster efficiently inhibits entry of SARS-CoV-2 omicron variant
por: Zhang, Wei, et al.
Publicado: (2022)

SARS CoV2 vaccine and aphasia
por: sookaromdee, Pathum, et al.
Publicado: (2021)

Vaccine inequity and hesitancy: Dual factors in the emergence of novel SARS-CoV-2 variants
por: Dhawan, Manish, et al.
Publicado: (2021)

SARS-CoV-2 Omicron Variant Neutralization in Serum from Vaccinated and Convalescent Persons
por: Rössler, Annika, et al.
Publicado: (2022)

A protein subunit vaccine booster following two doses of inactivated SARS-CoV-2 vaccine provides high neutralisation of SARS-CoV-2 and its variants in mice
por: Zhang, Rong, et al.
Publicado: (2022)

Identifying SARS-CoV-2 infections in South Africa: Balancing public health imperatives with saving lives
por: Baxter, Cheryl, et al.
Publicado: (2021)

SARS-CoV-2 Psychiatric Sequelae: An Urgent Need of Prevention
por: Bottemanne, Hugo, et al.
Publicado: (2021)

Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
por: Wang, Guo-Lin, et al.
Publicado: (2021)

The impact of SARS-CoV-2 variants on IBD management
por: Segal, Jonathan P, et al.
Publicado: (2021)

Plasma Neutralization of the SARS-CoV-2 Omicron Variant
por: Schmidt, Fabian, et al.
Publicado: (2021)

Where is the next SARS-CoV-2 variant of concern?
por: Dennehy, John J, et al.
Publicado: (2022)

SARS-CoV-2 incidence and vaccine escape
por: Thompson, Robin N, et al.
Publicado: (2021)

Effect of Vaccination on Transmission of SARS-CoV-2
por: Shah, Anoop S.V., et al.
Publicado: (2021)

Hemophagocytic lymphohistiocytosis and SARS-CoV-2 vaccination
por: Mungmunpuntipantip, Rujittika, et al.
Publicado: (2022)

Post SARS-CoV-2 vaccination effluvium
por: Luu, Ngoc-Nhi C., et al.
Publicado: (2023)

Field evaluations of four SARS-CoV-2 rapid antigen tests during SARS-CoV-2 Delta variant wave in South Africa
por: Samsunder, Natasha, et al.
Publicado: (2023)

Rapid genome sequencing in hospitals to identify potential vaccine-escape SARS-CoV-2 variants
por: Snell, Luke B, et al.
Publicado: (2021)

Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination
por: Yu, Xiaoqi, et al.
Publicado: (2022)

SARS-CoV-2 Omicron Variant Neutralization after mRNA-1273 Booster Vaccination
por: Pajon, Rolando, et al.
Publicado: (2022)

Implications of COVID-19 vaccine boosters amid the emergence of novel variants of SARS-CoV-2
por: Dhawan, Manish, et al.
Publicado: (2022)

Rapid identification and tracking of SARS-CoV-2 variants of concern
por: Chakraborty, Debojyoti, et al.
Publicado: (2021)

Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
por: Bager, Peter, et al.
Publicado: (2021)

SARS-CoV-2 rapid diagnostic tests for emerging variants
por: Bekliz, Meriem, et al.
Publicado: (2021)

Neutralization of the SARS-CoV-2 Deltacron and BA.3 Variants
por: Evans, John P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_i311ndv9ai1mn5nvhdbojqciqg